NPC's John O'Brien to Speak at ACCESS US 2025

  • June 8, 10:00am - June 10 11:00pm, 2025

NPC's John O'Brien will deliver the keynote address and join a panel to discuss drug pricing and patient access. 

ACCESS 2024

“Healthcare’s Defining Moment”

Join NPC at the US ACCESS Forum 2025. NPC President and CEO John O’Brien will deliver the keynote address at ACCESS US'25 in Austin, TX (June 8-10), exploring the critical challenges facing healthcare access in the new Trump Administration era. As the landscape transforms under Trump 2.0, this isn't just another conference — it's an essential strategic summit for healthcare leaders that will tackle:

  • IRA Year 2 implementation realities as price negotiations intensify
  • Trump Administration 2.0 policy shifts reshaping healthcare economics
  • AI Revolution applications transforming access strategies

Beyond provocative discussions, ACCESS US'25 offers hands-on workshops and executive roundtables to generate real solutions to your most pressing challenges. The question isn't whether healthcare faces disruption in 2025 — it's whether you'll be positioned to transform challenge into opportunity. Will your organization be represented at what has become the "Davos of Access"? See you in Austin to ensure you're shaping healthcare's future, not watching from the sidelines.

On June 9, from 9:15 AM – 10:00 AM CT, Dr. O’Brien will deliver the keynote presentation on “Healthcare Evolution in the Trump Administration.” Then, from 10:00 AM – 11:15 AM CT, Dr. O’Brien will join a plenary session panel alongside Mark Hansan of CareMetx, LLC, Sarah Emond of ICER, and Scott Howell of Blue Line Advisors, LLC. Mr. Hansan and Dr. Howell host the “Prescription for Better Access” podcast, and will record an episode live — covering the panel’s conversation on the “Future of US Drug Pricing and Patient Access.” 

More details below!

 

Monday, June 9th, 2025 | 9:15 AM - 10:00 AM CT

Keynote Presentation: Healthcare Evolution in the Trump Administration

Speaker: John O'Brien, President and CEO, National Pharmaceutical Council

Monday, June 9th, 2025 | 10:00 AM - 11:15 AM CT

Plenary 1: Live Prescription for Better Access Podcast: Future of US drug pricing and patient access

This session aims to educate the audience on the current US drug pricing and access landscape; explore the impact on patients and other stakeholders; present diverse stakeholder perspectives; and forecast the future and propose solutions.

Session Speakers:

  • Mark Hansan, Co-founder and Executive Chairman, CareMetx, LLC
  • Sarah Emond, President and Chief Executive Officer, Institute for Clinical and Economic Review (ICER)
  • Scott Howell, Owner, Blue Line Advisors, LLC
  • John O'Brien, President and CEO, National Pharmaceutical Council

Learn more about the conference

 

Event Speakers